Alfa Wassermann Separation Technologies (AWST) provides solutions for process development and industrial scale manufacturing to efficiently and reliably separate viruses and viral vectors in the development and manufacture of vaccines and other bioproducts. Our continuous flow ultracentrifuges are used for protocol development and small scale production, (PKII and the NEW electric drive ePKII), as well as industrial scale production (with our KII and the NEW electric drive eKII). Our new AW Promatix 1000™ BioPurification System incorporates ultracentrifugation technology, automated gradient preparation, sample loading, fraction collection and with its software provides ideal methodology development for direct transfer to production.

Alfa Wassermann offers an outstanding history of innovation, breadth of experience and commitment to customer service in its dedication to the biotechnology industry.

• Choice of Process Capacity – Research to pilot to manufacturing ultracentrifuges

• Multiple Procedures Possible – Continuous-flow or batch operations (rate-zonal or pelleting)

• High Yield, High Purity – Eliminating additional steps necessary with other techniques

• Time & Cost Savings – Patented linear scale-up / scale down technology

• Convenience – Single step combining enrichment and purification

• High Performance – 121,000 x g @ 40,500 rpm

• Peace of Mind – Ensured compliance with CE, CSA, cGMP and GAMP4 standards

• Comprehensive Traceability – 21 CFR Part 11 conformity

• Exceptional Reliability – Many units still running up to 35 years after delivery

• Outstanding Warranty – – 4000 hours for the air drive (equivalent to over 9 billion revolutions) and 3000 hours (up to 7.3 billion revolutions) for the electric drive – with an optional Lifetime Warranty.

• Total Support – Rapid response, world-wide on-site service; training and applications back-up

• Experienced Team – 40 years’ experience in continuous flow centrifugation

© 2007 Alfa Wassermann Separation Technologies  | All Rights Reserved.